Polycystic Ovary Syndrome
Reproductive·MeSH: Polycystic Ovary Syndrome
Prevalence
880.4 / 100K
Incidence
29.3 / 100K/yr
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| tildacerfont | SPRUCE BIOSCIENCES, INC. (SPRB) |
N/A(1)
| Drug | Company |
|---|---|
| Genetic analysis | Valneva SE (VALN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Polycystic Ovary Syndrome?
BioSniper tracks 2 drugs in development for Polycystic Ovary Syndrome across 2 companies.
How many clinical trials target Polycystic Ovary Syndrome?
There are 2 clinical trials targeting Polycystic Ovary Syndrome tracked by BioSniper.
What is the prevalence of Polycystic Ovary Syndrome?
The estimated prevalence of Polycystic Ovary Syndrome is approximately 880.4 per 100,000 population.
Deep-dive into Polycystic Ovary Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis